NSE: HCG | BSE: 539787

Momentum Trap

Download real time

678.40 -10.20 (-1.48%)

High vol. this week

NSE 12 Sep, 2025 3:31 PM (IST)

9,457.9

Market Cap

Above industry Median

0.6

Beta 1Year

Very Low volatility

Block Deal

Equity stake of 4.5% in Healthcare Global, worth Rs 437.9 crore, changes hands in a block deal See details

Healthcare Global Enterprises Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for HCG, BSE:539787 Healthcare Global Enterprises Ltd.

Healthcare Global Enterprises Ltd.

14 Aug 2021

678.40

-1.48%

Healthcare Global Enterprises

Hold: Healthcare Global Enterpri...

Target

ICICI Securities Limited

...

Healthcare Global Enterprises Ltd. has gained 23.66% in the last 3 Months

Healthcare Global Enterprises Ltd.

28 Jun 2021

678.40

-1.48%

HEALTHCARE GLOBAL ENTERPRISES LIMITED

Accumulate: Healthcare Global Enterpri...

Recommendation Target

Geojit BNP Paribas

Healthcare Global Enterprises Ltd is one of India's leading oncology treatment specialists with presence across the country. HCG revenues in Q4FY21 grew by 10.6% YoY to Rs.298 cr during the quarter with good momentum across existing centres inspite of decline in international patients. Consolidated operating EBITDA was Rs. 34.9 cr, reporting a growth of 11.6% YoY, amidst COVID-led disruptions in the quarter. Milann Fertility Centre delivered positive growth on QoQ basis across...

Promoters have decreased holdings from 71.22% to 62.46% in Jun 2025 qtr

Healthcare Global Enterprises Ltd.

15 Dec 2020

678.40

-1.48%

Healthcare Global Enterprises

Hold: Healthcare Global Enterpri...

Target

ICICI Securities Limited

HCG operates one of the largest private cancer care networks in India with end-to-end solutions available under a single corporate entity. This consists of 22 comprehensive cancer centres that provide a single point destination for complete cancer care. Most centres are on a lease or rental basis with some in partnership with local doctors or hospitals. Owing to exclusive agreement with vendors, HCG procures equipment on a deferred payment basis. We expect revenues from cancer network to grow at 10% CAGR to | 1365 crore over FY20-23E on the back of a ramp up in new hospitals....

Healthcare Global Enterprises Ltd. has gained 23.66% in the last 3 Months

Healthcare Global Enterprises Ltd.

09 Dec 2020

678.40

-1.48%

HEALTHCARE GLOBAL ENTERPRISES LIMITED

Buy: Healthcare Global Enterpri...

Geojit BNP Paribas

Healthcare Global Enterprises Ltd is one of India's leading oncology treatment specialists with presence across the country. Healthcare Global Enterprises operates one of the largest private sector cancer treatment centres in India with 22 cancer centres....

Healthcare Global En.. has an average target of 646.00 from 5 brokers.

Healthcare Global Enterprises Ltd.

10 Dec 2019

678.40

-1.48%

Healthcare Global Enterprises

Hold: Healthcare Global Enterpri...

ICICI Securities Limited

HCG operates one of the largest private cancer care networks in India with end-to-end solutions available under single corporate entity. This consisted of 21 comprehensive cancer centres that provide a single point destination for complete cancer care. Most centres are on lease or rental basis with some in partnership with local doctors or hospitals. Owing to exclusive agreement with vendors, HCG procures equipment on a deferred payment basis. We expect revenues from the HCG centres to grow at 16.2% CAGR to...

Promoters pledged 0.71% of shares in last quarter. Total pledge stands at 5.70% of promoter holdings

Healthcare Global Enterprises Ltd.

19 Sep 2017

678.40

-1.48%

Healthcare Global Enterprises

Mgmt Note: Healthcare Global Enterpri...

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research We met the management of Healthcare Global Enterprises (HCG), a leading cancer care hospital chain, to understand its unique model of single speciality focus (cancer care) and its future plans. HCG was started by Dr BS Ajaikumar in 2005. The company initially established 10 cancer centres with private funding. Currently, it operates 24 HCG facilities (18 cancer centres, two multi-speciality hospitals, three diagnostics and oneday care chemotherapy centre). HCG owns 1364 beds and a team of 200+ oncologists (FY17). Currently, Karnataka, Gujarat regions comprise...

Promoters have decreased holdings from 71.22% to 62.46% in Jun 2025 qtr

Healthcare Global Enterprises Ltd.

17 Apr 2017

678.40

-1.48%

Pick of the Week - Healthcare Global Enterprises

Buy: Healthcare Global Enterpri...

HDFC Securities

BUY Healthcare Global Enterprises at CMP Rs. 260 and add on dips to Rs. 260- 230 for the sequential targets of Rs. 305 & Rs. 348

Promoters pledged 0.71% of shares in last quarter. Total pledge stands at 5.70% of promoter holdings

Healthcare Global Enterprises Ltd.

16 Mar 2016

678.40

-1.48%

HealthCare Global Enterprises Limited

IPO Subscribe: Healthcare Global Enterpri...

AUM Capital

HealthCare Global Enterprises Limited (HCG) is one of the leading providers of speciality healthcare in India focused on cancer and fertility. Under the brand HCG, it operates the largest cancer care network & under the Milann brand it operates fertility centre in eight states in India. As on Dec 2015, HCG network consisted of 14 comprehensive cancer centres including centre of excellence in...

Healthcare Global Enterprises Ltd. has gained 23.66% in the last 3 Months

Healthcare Global Enterprises Ltd.

15 Mar 2016

678.40

-1.48%

Healthcare Global Enterprises Limited

Healthcare Global Enterpri...

Angel Broking

Healthcare Global Enterprises Ltd( HCG) is one of the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB as of May 31, 2015. The HCG network was ranked second in India and first in the South India region and Bengaluru in the oncology segment in the Times Health All In..

Healthcare Global Enterprises Ltd. is trading above all available SMAs

Healthcare Global Enterprises Ltd.

14 Mar 2016

678.40

-1.48%

Healthcare Global Enterprises - IPO

Healthcare Global Enterpri...

ICICI Securities Limited

Healthcare Global Enterprise (HCG) is a provider of specialty healthcare in India, focused on cancer and fertility. Under the HCG brand, the company operates the largest private cancer care network with a pan-India...

Geojit BNP Paribas increased Hold price target of Healthcare Global Enterprises Ltd. to 740.0 on 29 Aug, 2025.

Is Healthcare Global Enterprises Ltd. worth buying?

46 Votes:

Buy 73.91%

Sell 13.04%

Hold 13.04%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf